Author/Editor		Lizrova Preiningerova, Jana; Baumhackl, Ulf; Csepany, Tunde; Czaplinski, Adam; Deisenhammer, Florian; Derfuss, Tobias; Hojs-Fabjan, Tanja; Fazekas, Franz; Fuchs, Siegrid; Havrdova, Eva; Horvat-Ledinek, Alenka; Illes, Zsolt; Šega, Saša; Klimova, Eleonora; Komoly, Samuel; Kurča, Egon; Linnebank, Michael; Lisy, Lubomir; Mares, Jan; Prochazkova, Lubica; Csilla, Rozsa; Szilasiova, Jarmila; Stourac, Pavel; Talab, Radomir; Turčáni, Peter; Vachova, Marta; Vecsei, Laszlo; Vodušek, David B.; Zapletalova, Olga; Berger, Thomas
Title		Recommendations for the use of prolonged-release fampridine in patients with multiple sclerosis (MS)
Type		članek
Vol. and No.		Letnik 19, št. 5
Publication year		2013
Volume		str. 302-306
ISSN		1755-5930 - CNS neuroscience & therapeutics
Language		eng
Abstract		Prolonged-release fampridine (fampridine PR) is a potassium channel blocker that improves conductivity of signal on demyelinated axons in central nervous system. Fampridine PR has been approved to improve speed of walking in patients with multiple sclerosis. This statement provides a brief summary of data on fampridine PR and recommendations on practical use of the medication in clinical practice, prediction, and evaluation of response to treatment and patient management.
Keywords		multipla skleroza zdravljenje z zdravili centralni živčni sistem hoja, hitrost aminopiridin fampridin učinki zdravljenja